HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Evommune CEO Pena sells $381,736 in stock

Created at 4 Jun · 12:36 AM3 sources↑ Market-relevant3 events
IN SHORT

Evommune President & CEO Luis C. Pena sold company stock valued at $381,736. This follows a recent stock sale by director Cohen.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

$381,736stock sale value by CEO Pena

Who's Involved

Luis C. Pena
President & CEO of Evommune

↳ Why This Matters

Insider selling by a CEO can sometimes signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment.

Key facts

  • Evommune President & CEO Luis C. Pena sold company stock.
  • The value of the stock sale was $381,736.
  • This follows a recent stock sale by director Cohen.

Evommune President & CEO Luis C. Pena has sold shares valued at $381,736. The transaction involved the sale of company stock by the CEO. This follows a recent stock sale by Evommune director Cohen, who sold $123,093 in stock on November 29, 2023.

Frequently asked questions

Luis C. Pena is the President & CEO of Evommune.

He sold company stock valued at $381,736.

The specific date of this transaction was not provided in the content.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

4 Jun · 12:22 AM
Evommune director Cohen sold $123,093 in stock on November 29, 2023.
Investing.com via PiQSuite
4 Jun · 12:22 AM
Evommune CEO Luis C. Pena sold $381,736 in company stock.
Investing.com via PiQSuite
4 Jun · 12:07 AM
Evommune CSO Patel sold $379,000 worth of stock and acquired $51,000 in stock.
Investing.com via PiQSuite

Sources

T1
Evommune CSO Patel sells $379k, acquires $51k in stockm.piqsuite.com
T1
Evommune director Cohen sells $123,093 in stockm.piqsuite.com
T1
Evommune president & CEO Luis C. Pena sells $381,736 in stockm.piqsuite.com

Related Stories

Michael Burry Buys Flutter, DraftKings Shares on Prediction Market Threat
8 Jul · 9:51 PM
JPMorgan Hires Michael Flynn to Lead New Small-Cap Banking Business
8 Jul · 3:03 PM
Honeywell Technologies raises 2026 profit targets after reverse stock split
8 Jul · 9:08 PM
Levi Strauss raises annual outlook on steady denim demand
8 Jul · 8:17 PM
SK Hynix $28B ADR bookbuild closes Wednesday amid strong demand
8 Jul · 7:57 AM